FDA OKs First Drug for Hyperphagia in Prader-Willi Syndrome

[ad_1]

(MedPage Today) — The FDA approved extended-release diazoxide choline (Vykat XR) to treat the intense persistent sensation of hunger in patients 4 years of age and older with Prader-Willi syndrome, maker Soleno Therapeutics announced.
“The FDA…

[ad_2]

Source link : https://www.medpagetoday.com/endocrinology/growthdisorders/114856

Author :

Publish date : 2025-03-27 18:35:00

Copyright for syndicated content belongs to the linked Source.